Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH.

Gian Maria Busetto Riccardo LombardoCosimo De NunzioGiuseppe SantoroEdoardo TocciNicola SchiavoneAndrea TubaroGiuseppe CarrieriSteven A KaplanThomas R W Herrmann

Published in: Prostate cancer and prostatic diseases (2024)

Despite limitations, the review tentatively concluded that MISTs, including iTind, Rezūm, Urolift, Aquablation, and TPLA, appear comparable in sparing ejaculation. Long-term studies are essential to validate sustainability, and comparative research should assess trade-offs between MISTs and traditional surgeries. Incorporating patient-reported outcomes and quality of life assessments will enhance future investigations, refining MISTs as standard therapeutic options for LUTS/BPH.

Keyphrases

benign prostatic hyperplasia
patient reported outcomes
lower urinary tract symptoms
robot assisted
minimally invasive
case control